NewHold Investment Corp IV(NHIV)Stock Analysis
AI analysis on 6,000+ stocks →Deep AI analysis on 6,000+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
NHIV Stock Analysis & AI Quality Score
AI stock analysis and institutional research for NewHold Investment Corp IV (NHIV), a Financials sector company. NHIV is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. NHIV trades on the Nasdaq exchange and files with the SEC under CIK 2099767. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHIV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NewHold Investment Corp IV directly from SEC EDGAR.
Net Income
Q1 2026
$-38.0K
Track NHIV with AI-powered research
10 AI analysts debate this stock daily. Free to start.
Available Research
13F Pro tracks comprehensive data for NewHold Investment Corp IV including:
More Financials Companies
View all Financials →Unlock Full Research for NHIV
Get detailed financial analysis, insider activity, institutional flows, AI-powered debates, and quality rankings for NewHold Investment Corp IV and 6,000+ other companies.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NHIV a good stock to buy?
13F Pro's AI-powered analysis of NewHold Investment Corp IV (NHIV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NHIV are available on the NHIV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own NHIV?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NHIV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NewHold Investment Corp IV's investment landscape.